Synaptogenix【SNPX】株式ニュース

名称	銘柄コード	市場	種別
Synaptogenix Inc	SNPX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.16	-3.26%	4.75	08:55:30

始値	安値	高値	終値	前日終値
4.85	4.75	5.01	4.75	4.91

最新ニュース

日付	時間	ソース	タイトル
2024/5/16	06:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/07	22:00	PRNUS	Synaptogenix Applauds DEA Proposal to Reclassify Cannabis..
2024/4/24	22:15	PRNUS	Synaptogenix Regains Compliance with Nasdaq Minimum Bid..
2024/4/09	22:15	PRNUS	Synaptogenix Increases Stake in Innovative Psilocybin Drug..
2024/4/03	21:00	PRNUS	Synaptogenix Announces Reverse Stock Split to Maintain..
2024/2/07	00:16	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2023/12/22	07:00	EDGAR2	Form 8-K - Current report
2023/12/19	23:00	PRNUS	Synaptogenix President Daniel L. Alkon, M.D. Honored for..
2023/12/06	23:00	PRNUS	Synaptogenix Joins Leading Neuroscientists and Academics as..
2023/11/15	07:05	EDGAR2	Form ARS - Annual Report to Security Holders
2023/11/14	07:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
2023/11/07	07:00	EDGAR2	Form 8-K - Current report
2023/11/04	06:00	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2023/11/02	22:00	PRNUS	Synaptogenix Acquires Significant Stake in Cannasoul..
2023/9/26	22:00	PRNUS	Synaptogenix Announces Peer-Reviewed Publication of..
2023/9/23	05:05	EDGAR2	Form 8-K - Current report
2023/9/07	22:00	PRNUS	Bryostatin-1 from Synaptogenix Shows Statistically..
2023/8/15	06:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/19	22:00	PRNUS	Synaptogenix and Cleveland Clinic to Submit Investigational..
2023/7/19	21:55	EDGAR2	Form 8-K - Current report
2023/7/13	22:00	PRNUS	Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in..